Challenges in measuring antibiotic consumption

Current Infectious Disease Reports

Volumn 15, Issue 6, 2013, Pages 559-563

  Gravatt, Leigh Anne Hylton ^a   Pakyz, Amy L ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Antibacterial measurement; Days of therapy; Defined daily dose; Prescribed daily dose

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFTRIAXONE; CIPROFLOXACIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BODY WEIGHT; DRUG USE; DRUG UTILIZATION; GROUPS BY AGE; HUMAN; PHARMACY; PRESCRIPTION;

EID: 84890666369     PISSN: 15233847     EISSN: 15343146     Source Type: Journal    
DOI: 10.1007/s11908-013-0374-9     Document Type: Article

References (23)

1. Ibrahim OM, Polk RE. Benchmarking antimicrobial drug use in hospitals. Expert Rev Anti-Infect Ther. 2012;10:445-57.
2. Morris AM, Brener S, Dresser L, et al. Use of a structured panel process to define quality metrics for antimicrobial stewardship programs. Infect Control Hosp Epidemiol. 2012;33:500-6.
3. Dellit TH, Owens RC, McGowan JE, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44:159-77.
4. The World Health Organization. WHO Collaborating Centre for Drug Statistics Methodology. Anatomical Therapeutic Chemical (ATC). http://www.whocc.no/atc-ddd-index/) Accessed June 24, 2013.
5. Lesch CA, Itokazu GS, Danziger LH, Weinstein RA. Multi-hospital analysis of antimicrobial usage and resistance trends. Diagn Microbiol Infect Dis. 2001;41:149-54.
6. Polk RE, Johnson CK, McClish D, Wenzel RP, Edmond MB. Predicting hospital rates of fluoroquinolone-resistant Pseudomonas aeruginosa from fluoroquinolone use in US hospitals and their surrounding communities. Clin Infect Dis. 2004;39:497-503.
7. Carling PC, Fung T, Coldiron JS. Parenteral antibiotic use in acute-care hospitals: a standardized analysis of fourteen institutions. Clin Infect Dis. 1999;29:1189-96.
8. McDonald LC, Yu HT, Yin HC, et al. Correlates of antibiotic use in Taiwan hospitals. Infect Control Hosp Epidemiol. 2001;22:565-71.
9. Monnet D. Measuring antimicrobial use: the way forward. Clin Infect Dis. 2007;44:671-3.
10. Polk RE, Fox C, Mahoney A, Letcavage J, MacDougall C. Measurement of adult antibacterial drug use in 130 US hospitals: comparison of defined daily dose and days of therapy. Clin Infect Dis. 2007;44:664-70.
11. Centers for Disease Control and Prevention. Antimicrobial Use and Resistance (AUR) Module. http://www.cdc.gov/nhsn/PDFs/pscManual/11pscAURcurrent. pdf. Accessed June 4, 2013.
12. Kubin CJ, Jia H, Alba LR, Furuya EY. Lack of significant variability among different methods for calculating antimicrobial days of therapy. Infect Control Hosp Epidemiol. 2012;33:421-3.
13. Liem TB, Heerdink ER, Egberts ACG, Rademaker CMA. Quantifying antibiotic use in paediatrics: a proposal for neonatal DDDs. Eur J Clin Microbiol Infect Dis. 2010;29:1301-3.
14. Liem TB, Krediet TG, Fleer A, et al. Variation in antibiotic use in neonatal intensive care units in the Netherlands. J Antimicrob Chemother. 2010;65:11270-5.
15. de With K, Bestehorn H, Steib-Bauert M, Kern WV. Comparison of defined versus recommended versus prescribed daily doses for measuring hospital antibiotic consumption. Infection. 2009;37:349-52.
16. Amadeo B, Zarb P, Muller A. European Surveillance of Antibiotic Consumption (ESAC) point prevalence survey 2008: paediatric antimicrobial prescribing in 32 hospitals of 21 European countries. J Antimicrob Chemother. 2010;65:2247-52.
17. Pakyz AL, Gurgle HE, Ibrahim OM, Oinonen MJ, Polk RE. Trends in antibacterial use in the hospitalized pediatric patients in United States Academic Medical Centers. Infect Control Hosp Epidemiol. 2009;30:600-3.
18. World Health Organization Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC Classification and DDD assignment. 2006. Available at http://www.whocc.no/atc-ddd-publi-cations/guidelines/ (Accessed June 28th, 2013)
19. Zhang W, Shen X, Bergman U, et al. Drug utilization 90% (DU90%) profiles of antibiotics in five Chinese children's hospitals (2002-2006). Int J Antimicrob Agents. 2008;32:250-5.
20. • Porta A, Hsia Y, Doerholt K, et al. Comparing neonatal and paediatric antibiotic prescribing between hospitals: a new algorithm to help international benchmarking. J Antimicrob Chemother. 2012;67:1278-86. This paper proposed a new three-step process for evaluating antibiotic use in hospitalized children. The first step is to stratify children by weight categories on the basis of the number of antimicrobials used, then to compare the mg/kg/day dosing and, lastly, to compare overall drug exposure using the DDD/100 bed days and the PDD/100 bed days between the various weight categories. It highlights the usefulness of DDD/100 bed days and the PDD/100 bed days when stratified by weight bands and how this may be a more meaningful comparison among pediatric groups.
21. Jha AK, Burke MF, DesRoches C, et al. Progress toward meaningful use: hospitals' adoption of electronic health records. Am J Manag Care. 2011; 17 (12 Spec No.): SP 117-24.
22. • Schwartz DN, Evans RS, Camins BC, et al. Deriving measures of intensive care unit antimicrobial use from computerized pharmacy data: methods, validation, and overcoming barriers. Infect Control Hosp Epidemiol. 2011;32:472-80. This paper describes the experiences of extracting antimicrobial usage data from the intensive care unit from four different hospital computerized systems. It delineates the errors that were found upon validation processes and describes suggestions for avoiding them.
23. Schirmer PL, Mercier RC, Ryono RA, et al. Comparative assessment of antimicrobial usage measures in the department of veterans affairs. Infect Control Hosp Epidemiol. 2012;33:409-11.